Industry updates with Dusko Ilic: August 2023

Written by Dusko ILIC
Cell therapy Clinical trials FDA Gene therapy Industry developments Report

Read highlights from the August installment of Dusko Ilic’s industry news, which discusses the latest developments and news in regenerative medicine and stem cell research, and is published every month in Regenerative Medicine. Every month, Dusko comments on regenerative medicine industry news of note. Read the full update for August 2023 in Regenerative Medicine here >>> Find previous updates here>>> What happened this month that you were expecting? Let Bluerock rock BlueRock Therapeutics (MA, USA), a clinical-stage cell therapy company and wholly owned, independently operated subsidiary of Bayer AG (Leverkusen, Germany), announced details of the positive data from the Phase...

To view this content, please register now for access

It's completely free